National Nutrition and Food Technology Research Institute, Department of Clinical Nutrition & Dietetics, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
School of Nutrition and Food Science, Shiraz University of Medical Science, Iran.
Nutr Neurosci. 2022 May;25(5):963-975. doi: 10.1080/1028415X.2020.1826763. Epub 2020 Oct 15.
Food addiction (FA) is an important contributor to obesity. Alterations in gut microbiota (GM) diversity and composition have also been proposed to play a pivotal role in obesity pathogenesis. This trial aimed to assess the effects of probiotic supplementation on the anthropometric indices, eating behavior, and hormone levels of obese women with FA.
This randomized, double-blind, placebo-controlled clinical trial was conducted among obese women with FA. Participants ( = 62) received a restricted calorie diet (RCD) plus either probiotic, or placebo for 12 weeks. Anthropometric measurements, biochemical markers, eating behavior and appetite were assessed during the study period.
Probiotics administration significantly reduced weight, body mass index (BMI), waist circumference (WC), waist to hip ratio (WHR), body fat percentage (BFP), and trunk fat percentage (TFP) compared to the placebo group ( < 0.001). Also, a significant improvement was observed in eating behavior in the probiotic group compared to the placebo group ( < 0.001).Serum levels of oxytocin increased and NPY decreased significantly in the probiotic group compared to the placebo group ( = 0.02, = 0.002, respectively). Moreover, leptin level significantly decreased in the probiotic group compared to the baseline values ( < 0.001), while probiotics did not cause a greater significant reduction in leptin level, compared to the placebo group.
Multi-probiotic supplementation may have beneficial effects on anthropometric indices, eating behavior, and some appetite-regulating hormones in obese women with FA. Iranian Registry of Clinical Trials identifier: IRCT20131228015968N5.
食物成瘾(FA)是肥胖的一个重要原因。肠道微生物多样性和组成的改变也被认为在肥胖发病机制中起关键作用。本试验旨在评估益生菌补充对 FA 肥胖女性的人体测量指标、饮食行为和激素水平的影响。
这是一项随机、双盲、安慰剂对照的临床试验,在 FA 肥胖女性中进行。参与者(n=62)接受限制热量饮食(RCD)加益生菌或安慰剂治疗 12 周。在研究期间评估了人体测量指标、生化标志物、饮食行为和食欲。
与安慰剂组相比,益生菌组的体重、体重指数(BMI)、腰围(WC)、腰臀比(WHR)、体脂肪百分比(BFP)和躯干脂肪百分比(TFP)显著降低(<0.001)。此外,与安慰剂组相比,益生菌组的饮食行为也得到了显著改善(<0.001)。与安慰剂组相比,益生菌组的催产素血清水平显著升高,神经肽 Y(NPY)水平显著降低(=0.02,=0.002)。此外,与基线值相比,益生菌组的瘦素水平显著降低(<0.001),而与安慰剂组相比,益生菌组的瘦素水平并没有更大的显著降低。
多益生菌补充可能对 FA 肥胖女性的人体测量指标、饮食行为和一些调节食欲的激素有有益的影响。
IRCT20131228015968N5。